Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee hands down positive opinion to extend Kyprolis indication

May 30, 2016

Saxagliptin/dapagliflozin receives positive opinion in E.U.

May 30, 2016

EMA committee recommends approval of Epclusa for hepatitis C

May 30, 2016

EMA committee does not support approval of Ninlaro capsules

May 30, 2016

EMA's CHMP gives positive opinion on brentuximab vedotin for post-transplant Hodgkin's lymphoma

May 30, 2016

EMA begins review of guidelines governing first-in-human trials

May 30, 2016

Humira receives CHMP positive opinion to treat certain forms of noninfectious uveitis

May 30, 2016

Merck & Co. receives positive opinion for Zepatier in the E.U.

May 30, 2016

EMA committee recommends approval of Revestive for pediatric patients with short bowel syndrome

May 27, 2016

EMA accepts MAA for Pfizer's Trumenba

May 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...